Gov. Pritzker announced that global biotherapeutics firm CSL will invest nearly $1.5 billion to construct a new manufacturing facility in Kankakee, marking one of the largest life sciences investments ...

CSL’s new Illinois investment adds to over $3B spent on U.S. operations since 2018. The expansion will create at least 300 ...

CSL has gotten the Memo about the value of recombinant polyclonal immunoglobulin (IgG) antibodies. The company is signing on to a collaboration and option agreement with Memo Therapeutics that could ...

CSL to downsize one-third of R&D division, AFR reports Company has not confirmed the number of job reductions Shares up 3% at over 6-week high July 15 (Reuters) - Australian biotech giant CSL Ltd (CSL ...

Shares of biotech company CSL plunged after the company announced that Chief Executive Officer Paul McKenzie will step down.

CSL is laying off up to 15% of its workforce as the Australian pharma looks to cut R&D costs and spin out its vaccine subsidiary in a wide-ranging restructure. The Melbourne-headquartered company will ...

CSL Limited (OTCQX:CSLLY) (OTCQX:CMXHF), an Australian biotech focused on developing vaccines and blood-derived therapies, on Tuesday announced plans to invest approximately $1.5B in the U.S. over the ...

CSL recognized in Forbes and Statista's Best Large-sized Employer category for the fourth time since 2018. KING OF PRUSSIA, Pa., Feb. 21, 2023 /PRNewswire/ -- Global biotechnology leader CSL has again ...

Battling lower vaccination rates in the US under the Trump administration’s public health policies and spiralling blood plasma sales in China, Mr Naylor faces a sceptical investment community fretting ...

CSL Limited (OTC:CSLLY) and Arcturus Therapeutics (NASDAQ:ARCT) announced the results of a Phase 3 head-to-head study of ARCT-154, a self-amplifying (sa-mRNA) COVID-19 vaccine, compared to Pfizer ...